Linezolid

Linezolid fights bacterial infections by stopping bacteria from making the proteins they need to survive and multiply ^{[1, 2]}.

Bacteria use ribosomes (molecular machines) to build proteins from genetic instructions. This process involves several steps. Linezolid interferes at the very first step — it binds to the 23S ribosomal RNA of the 50S ribosomal subunit and prevents the formation of the 70S initiation complex, which is required for protein synthesis to begin ^{[1, 2]}.

Because linezolid blocks protein synthesis at an earlier stage than other antibiotics (like macrolides or tetracyclines, which act at later steps), there is no cross-resistance with those drug classes ^[2]. This unique mechanism is what makes linezolid effective against bacteria that have become resistant to many other antibiotics, including MRSA and VRE.

Linezolid is bacteriostatic (stops bacterial growth) against staphylococci and enterococci, and bactericidal (kills bacteria) against most streptococci ^[1].

Days 1-3: Linezolid begins working against the infection immediately. Because of its 100% oral bioavailability, oral and IV formulations are equally effective ^[1]. You may begin to feel improvement in infection symptoms (fever reduction, decreased pain) within 48-72 hours, though the full course must be completed.

Days 3-7: Continued improvement is expected. Your healthcare team will monitor clinical response and may obtain follow-up cultures. Side effects during short courses are generally mild — nausea, headache, and diarrhea are most common.

Days 7-14: Most treatment courses are 10-14 days in length ^[1]. By the end of the course, the infection should be substantially improved or resolved.

Longer courses (>14 days): When linezolid is used for extended periods (>2 weeks), the risk of serious side effects increases, particularly myelosuppression (low blood counts), peripheral neuropathy, and optic neuropathy ^[1]. Weekly complete blood counts are recommended for courses longer than 2 weeks.

Food: Linezolid can be taken with or without food ^[1]. Food does not affect absorption.

Tyramine-containing foods (IMPORTANT): Linezolid has weak monoamine oxidase (MAO) inhibitory activity ^[1]. Consuming large amounts of tyramine-rich foods could theoretically cause a hypertensive reaction (dangerous blood pressure spike). Foods high in tyramine include aged cheeses (cheddar, Swiss, parmesan), fermented or smoked meats (salami, pepperoni), draft beer, tap beer, soy sauce, sauerkraut, and fermented soy products. While the MAO inhibition is weak, patients should avoid consuming large quantities of these foods during treatment.

Alcohol: Moderate alcohol consumption is unlikely to interact with linezolid. However, draft/tap beers have higher tyramine content than bottled beer and should be limited.

Caffeine: No specific interaction, though excessive caffeine may worsen insomnia, a reported side effect.

Linezolid dosing is the same for oral and IV formulations due to 100% oral bioavailability ^[1].

Adults: - VRE infections (including bacteremia): 600 mg every 12 hours for 14-28 days ^[1] - Nosocomial pneumonia (including MRSA): 600 mg every 12 hours for 10-14 days ^[1] - Community-acquired pneumonia: 600 mg every 12 hours for 10-14 days ^[1] - Complicated skin and skin structure infections (including MRSA): 600 mg every 12 hours for 10-14 days ^[1] - Uncomplicated skin infections: 400 mg every 12 hours for 10-14 days ^[1]

Children: - Neonates to 11 years: 10 mg/kg every 8 hours ^[1] - 12 years and older: Adult dosing ^[1]

Renal impairment: No dose adjustment needed ^[1]. However, the two primary metabolites accumulate in renal impairment — monitor for toxicity.

Hepatic impairment: No dose adjustment in mild to moderate impairment ^[1].

Monitoring: CBC weekly if treatment exceeds 2 weeks ^[1]. Monitor for visual changes and symptoms of peripheral neuropathy, especially with prolonged use.

Generic linezolid has significantly reduced costs compared to brand-name Zyvox ^{[1, 3]}.

Typical pricing (approximate 2025 prices): - Brand-name Zyvox tablets (600 mg): $70-100 per tablet - Generic linezolid tablets (600 mg): $3-10 per tablet - Brand-name oral suspension: $1,000-2,000 per bottle - IV formulation: Variable institutional pricing

Savings strategies: - Generic substitution: Generic linezolid has been available since 2015 ^[3]. Most prescriptions and institutional formularies use generic. - Oral conversion: Because oral and IV linezolid are equally effective, early conversion from IV to oral saves substantial costs in hospitalized patients ^[1]. - Insurance: Most insurance plans cover generic linezolid, though prior authorization is often required due to its specialized use. - Patient assistance: Pfizer (original manufacturer) offers assistance programs for eligible patients.

Pregnancy: Animal studies showed decreased fetal viability and fetal body weight at doses that also caused maternal toxicity ^[1]. There are no adequate and well-controlled studies in pregnant women. Linezolid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus — typically reserved for life-threatening infections where no safer alternative exists.

Breastfeeding: Linezolid is excreted in rat milk; human breast milk excretion data are limited ^[1]. Because of the potential for adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, considering the severity of the infection being treated.

Generic linezolid has been available since 2015 ^[3].

Brand name (Zyvox): - Manufactured by Pfizer - Tablets: 600 mg - Oral suspension: 100 mg/5 mL - IV solution: 200 mg/100 mL, 600 mg/300 mL premixed bags

Generic linezolid: - Available in tablet and IV formulations from multiple manufacturers - Rated therapeutically equivalent by the FDA - Dramatic cost reduction compared to brand

Unique advantage: The 100% oral bioavailability is clinically significant — many serious infections treated with IV linezolid can be transitioned to oral tablets without any loss of efficacy ^[1]. This can shorten hospital stays and reduce costs.

Alternative antibiotics for MRSA: - Vancomycin (IV): Historically the gold standard but requires IV access and drug level monitoring - Daptomycin (Cubicin): IV only; not effective for pneumonia - Tedizolid (Sivextro): Newer oxazolidinone with once-daily dosing and potentially fewer side effects